These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16118494)

  • 1. The association of metabolic syndrome with atrial fibrillation: an emerging epidemiological and pathophysiological hypothesis.
    Korantzopoulos P; Kokkoris S; Papaioannides D
    Cardiology; 2005; 104(3):148-9. PubMed ID: 16118494
    [No Abstract]   [Full Text] [Related]  

  • 2. The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications.
    Gersh BJ; Tsang TS; Seward JB
    Trans Am Clin Climatol Assoc; 2004; 115():149-59; discussion159-60. PubMed ID: 17060964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.
    Echahidi N; Mohty D; Pibarot P; Després JP; O'Hara G; Champagne J; Philippon F; Daleau P; Voisine P; Mathieu P
    Circulation; 2007 Sep; 116(11 Suppl):I213-9. PubMed ID: 17846306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome.
    Chang SL; Tuan TC; Tai CT; Lin YJ; Lo LW; Hu YF; Tsao HM; Chang CJ; Tsai WC; Chen SA
    Am J Cardiol; 2009 Jan; 103(1):67-72. PubMed ID: 19101232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for atrial fibrillation: Not always severe heart disease, not always so 'lonely'.
    Rosiak M; Dziuba M; Chudzik M; Cygankiewicz I; Bartczak K; Drozdz J; Wranicz JK
    Cardiol J; 2010; 17(5):437-42. PubMed ID: 20865672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial fibrillation. Epidemiology and physiopathology].
    Iuliano L; Micheletta F
    Haematologica; 2001 Sep; 86(9 Suppl):1-4. PubMed ID: 11759617
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial Fibrillation. Foreword.
    Crawford MH
    Cardiol Clin; 2009 Feb; 27(1):xiii. PubMed ID: 19111756
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiological profile of atrial fibrillation: a contemporary perspective.
    Tsang TS; Miyasaka Y; Barnes ME; Gersh BJ
    Prog Cardiovasc Dis; 2005; 48(1):1-8. PubMed ID: 16194688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenetic aspects of hypertension in case of metabolic syndrome].
    Simonenko VB; Medvedev IN; Kumova TA
    Voen Med Zh; 2010 Sep; 331(9):41-4. PubMed ID: 21254528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of arterial hypertension in the scope of metabolic syndrome].
    Riazanov AS; Arakeliants AA; Iurenenv AP
    Ter Arkh; 2003; 75(3):86-8. PubMed ID: 12718232
    [No Abstract]   [Full Text] [Related]  

  • 11. A complex constellation of interrelated conditions.
    Campbell ML
    Med Econ; 2009 Sep; 86(17):35-7. PubMed ID: 19806760
    [No Abstract]   [Full Text] [Related]  

  • 12. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery.
    Girerd N; Pibarot P; Fournier D; Daleau P; Voisine P; O'Hara G; Després JP; Mathieu P
    Eur Heart J; 2009 May; 30(10):1270-8. PubMed ID: 19329496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential atrial arrhythmogenicity of adipocytes: implications for the genesis of atrial fibrillation.
    Lin YK; Chen YJ; Chen SA
    Med Hypotheses; 2010 Jun; 74(6):1026-9. PubMed ID: 20149554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, insulin resistance, and the metabolic syndrome.
    Natali A; Ferrannini E
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.
    Ostgren CJ; Merlo J; Råstam L; Lindblad U
    Diabetes Obes Metab; 2004 Sep; 6(5):367-74. PubMed ID: 15287930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome: protective obesity].
    Nau JY
    Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension, stroke and the impact of atrial fibrillation.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1287-9. PubMed ID: 19018678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dysmetabolic symptomatic arterial hypertension and dysmetabolic disease].
    Bokarev IN; Shubina OI
    Klin Med (Mosk); 2009; 87(8):67-71. PubMed ID: 19827536
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women".
    Barrios V; Escobar C; Echarri R
    Circulation; 2010 Feb; 121(5):e29. PubMed ID: 20142460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.